Richard H. Parrish II is a pharmacist, scholar, and educator whose career of more than four decades has
been defined by a sustained commitment to understanding and shaping the policy frameworks that govern pharmaceutical use, regulation, and access. He holds a Ph.D. in social, administrative, and clinical pharmacy from the University of Minnesota, a master of science degree in pharmacy care systems from Auburn University, and a bachelor of science degree in pharmacy from The Ohio State University. He holds active licensure in Ohio and Pennsylvania.
Dr. Parrish’s foundational contribution to pharmaceutical policy is his book Defining Drugs: How Government Became the Arbiter of Pharmaceutical Fact (Transaction Publishers, 2003; Routledge paperback edition with new introduction, 2016), which examines the historical and sociolegal processes by which federal authority came to define the boundaries of pharmaceutical legitimacy in the United States. This work, grounded in his doctoral research and supported by a grant from the American Institute of the History of Pharmacy, established him as a distinctive voice at the intersection of pharmacy practice, regulatory history, and governance theory. His 2026 article “Genomic Medicine and Individual Autonomy: Reflections on Knowledge Societies and Governmentality,” published in the International Journal of Environmental Research and Public Health, extends this work into the era of precision medicine and data governance.
Richard H. Parrish II is a pharmacist, scholar, and educator whose career of more than four decades has
been defined by a sustained commitment to understanding and shaping the policy frameworks that govern pharmaceutical use, regulation, and access. He holds a Ph.D. in social, administrative, and clinical pharmacy from the University of Minnesota, a master of science degree in pharmacy care systems from Auburn University, and a bachelor of science degree in pharmacy from The Ohio State University. He holds active licensure in Ohio and Pennsylvania.
Dr. Parrish’s foundational contribution to pharmaceutical policy is his book Defining Drugs: How Government Became the Arbiter of Pharmaceutical Fact (Transaction Publishers, 2003; Routledge paperback edition with new introduction, 2016), which examines the historical and sociolegal processes by which federal authority came to define the boundaries of pharmaceutical legitimacy in the United States. This work, grounded in his doctoral research and supported by a grant from the American Institute of the History of Pharmacy, established him as a distinctive voice at the intersection of pharmacy practice, regulatory history, and governance theory. His 2026 article “Genomic Medicine and Individual Autonomy: Reflections on Knowledge Societies and Governmentality,” published in the International Journal of Environmental Research and Public Health, extends this work into the era of precision medicine and data governance.